Knowledge Hub
Knowledge Hub
Free, evidence-based resources for patients, families and health professionals navigating neuroendocrine cancer in Aotearoa New Zealand. Written in plain language, reviewed by clinicians.
Page 1 of 1
BookletThis booklet has been developed to provide information about neuroendocrine tumours (NETs) for patients and their families.
Read
There are various types of scans that may or may not be suitable for your type of NETs. Here is a summary of some scans you might encounter.
What G1, G2 and G3 mean for a neuroendocrine cancer diagnosis – plain-language explanation of grade, Ki-67, and how they shape treatment options.
Read
Neuroendocrine Tumours (NETs) is an umbrella name for a number of different types of tumours, which can arise in different areas of the body. It can be…
Read
BookletPatient guide to peptide receptor radionuclide therapy (PRRT) for NETs.
Read
Treatments for neuroendocrine cancers vary from person to person and may be one or more of the options listed below.
Read
ToolPlain-language definitions of common neuroendocrine tumour (NET) terms – for patients, whānau, and care partners. Updated as new treatments and tests come into NZ practice.
Read
The FDA is expected to decide on ITM-11 (177Lu-edotreotide) for GEP-NETs by 28 August 2026, based on the Phase 3 COMPETE trial results.
Read
A first-in-human trial of [212Pb]VMT-α-NET, a targeted alpha-particle therapy for SSTR2-positive NETs, has reported early activity at ASCO GI 2026.
ReadNeuroendocrine tumours (NETs) is the umbrella term for a group of unusual, often slow-growing cancers.
ReadThe CABINET trial led the FDA to approve cabozantinib in March 2025 for adults and adolescents with previously treated advanced pancreatic and extra-pancreatic NETs.
ReadThe Phase 3 NETTER-2 trial showed Lutathera plus octreotide nearly tripled progression-free survival when used as first-line therapy in grade 2/3 GEP-NETs.
ReadMost neuroendocrine cancers aren't inherited, but a small number are linked to hereditary syndromes like MEN1, MEN2 and VHL. Here's what to know.
ReadNeuroendocrince Cancer NZ is an organisation dedicated to revolutionising the way that neuroendocrine tumours are diagnosed and managed in New Zealand.
Read